Scpharmaceuticals Inc 's (SCPH) Outlook - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Scpharmaceuticals Inc   (NASDAQ: SCPH)
 



  Scpharmaceuticals Inc Outlook

On January 10 2025 the Scpharmaceuticals Inc provided following guidance

nnscPharmaceuticals Inc. Releases Preliminary Unaudited Financial Projections for Fourth Quarter and Full Year 2024nn

scPharmaceuticals Inc. has shared its preliminary unaudited financial results for the fourth quarter and full year of 2024. According to the company's estimates, the net revenue for the fourth quarter is anticipated to fall within the range of $12 million to $12.3 million. This figure indicates a remarkable growth rate of approximately 99% compared to the same quarter in 2023, when considering the midpoint of the projected revenue range.

Preliminary unaudited net revenue for the fourth quarter of 2024 is projected to be between $12 million and $12.3 million, reflecting an impressive growth of 99% over the fourth quarter of 2023 based on the midpoint of the range.

,





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.